Neogen (NEOG) Q2 Earnings and Revenues Miss Estimates

HomeInvesting

Neogen (NEOG) Q2 Earnings and Revenues Miss Estimates

Neoge


Neogen (NEOG) got here out with quarterly earnings of $0.31 per share, lacking the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.31 per share a yr in the past. These figures are adjusted for non-recurring objects.

This quarterly report represents an earnings shock of -3.12%. 1 / 4 in the past, it was anticipated that this maker of medical testing kits would submit earnings of $0.29 per share when it really produced earnings of $0.28, delivering a shock of -3.45%.

Over the past 4 quarters, the corporate has surpassed consensus EPS estimates simply as soon as.

Neogen, which belongs to the Zacks Medical – Merchandise business, posted revenues of $107.80 million for the quarter ended November 2019, lacking the Zacks Consensus Estimate by 3.66%. This compares to year-ago revenues of $107.10 million. The corporate has not been in a position to beat consensus income estimates during the last 4 quarters.

The sustainability of the…



nasdaq.com